3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
38
Stomach Neoplasms
25
Rectal Neoplasms
19
Pancreatic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
14
Colonic Neoplasms
14
Esophageal Neoplasms
12
Adenocarcinoma Of Esophagus
12
Carcinoma, Non-Small-Cell Lung
10
Neoplasms
9
Neoplasm Metastasis
9
Adenocarcinoma
9
Cholangiocarcinoma
8
Biliary Tract Neoplasms
6
Ovarian Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Hepatocellular
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma
3
Bile Duct Neoplasms
3
Advanced Solid Tumors
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Recurrence
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Oxaliplatin
×
90 days
×
Clear all
No trials found.